APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer 338

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Poloxamer 338 Industry Growth and Trends Forecast to 2032

22 December 202571 pages

Choose your research edition.

Industry ResearchPoloxamer 338 Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer 338 Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Poloxamer 338 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer 338 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer 338 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Poloxamer 338 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poloxamer 338 include BASF, Croda, Comercial Química Massó and CD Formulation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Poloxamer 338 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Poloxamer 338 market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Poloxamer 338 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Poloxamer 338.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Poloxamer 338 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Poloxamer 338 Market by Company

BASF

Croda

Comercial Química Massó

CD Formulation

Poloxamer 338 Segment by Type

Purity 99%

Purity 99.9%

Others

Poloxamer 338 Segment by Application

Cosmetic

Pharmaceuticals

Others

Poloxamer 338 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer 338 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer 338 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer 338.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Poloxamer 338 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Poloxamer 338 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity 99% Table 2. Major Company of Purity 99.9% Table 3. Major Company of Others Table 4. Global Poloxamer 338 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 6. Global Poloxamer 338 Sales Market Share in Volume by Type (2021-2026) Table 7. Global Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 8. Global Poloxamer 338 Sales Market Share in Value by Type (2021-2026) Table 9. Global Poloxamer 338 Price by Type (2021-2026) & (US$/Ton) Table 10. Global Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 11. Global Poloxamer 338 Sales Market Share in Volume by Type (2027-2032) Table 12. Global Poloxamer 338 Sales by Type (2027-2032) & (US$ Million) Table 13. Global Poloxamer 338 Sales Market Share in Value by Type (2027-2032) Table 14. Global Poloxamer 338 Price by Type (2027-2032) & (US$/Ton) Table 15. North America Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 16. North America Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 18. Europe Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 22. Latin America Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Poloxamer 338 Sales by Type (2021-2026) & (US$ Million) Table 25. Poloxamer 338 Industry Trends Table 26. Poloxamer 338 Industry Drivers Table 27. Poloxamer 338 Industry Opportunities and Challenges Table 28. Poloxamer 338 Industry Restraints Table 29. Global Poloxamer 338 Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Poloxamer 338 Revenue Market Share by Company (2021-2026) Table 31. Global Poloxamer 338 Sales by Company (2021-2026) & (Tons) Table 32. Global Poloxamer 338 Sales Share by Company (2021-2026) Table 33. Global Poloxamer 338 Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Poloxamer 338 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Poloxamer 338 Major Company Production Sites and Headquarters Table 36. Global Poloxamer 338 Company, Product Type & Application Table 37. Global Poloxamer 338 Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Poloxamer 338 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Poloxamer 338 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Poloxamer 338 Sales by Region (2021-2026) & (Tons) Table 42. Global Poloxamer 338 Sales Market Share in Volume by Region (2021-2026) Table 43. Global Poloxamer 338 Sales by Region (2021-2026) & (US$ Million) Table 44. Global Poloxamer 338 Sales Market Share in Value by Region (2021-2026) Table 45. Global Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Poloxamer 338 Sales by Region (2027-2032) & (Tons) Table 47. Global Poloxamer 338 Sales Market Share in Volume by Region (2027-2032) Table 48. Global Poloxamer 338 Sales by Region (2027-2032) & (US$ Million) Table 49. Global Poloxamer 338 Sales Market Share in Value by Region (2027-2032) Table 50. Global Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Poloxamer 338 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 53. Global Poloxamer 338 Sales Market Share in Volume by Application (2021-2026) Table 54. Global Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 55. Global Poloxamer 338 Sales Market Share in Value by Application (2021-2026) Table 56. Global Poloxamer 338 Price by Application (2021-2026) & (US$/Ton) Table 57. Global Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 58. Global Poloxamer 338 Sales Market Share in Volume by Application (2027-2032) Table 59. Global Poloxamer 338 Sales by Application (2027-2032) & (US$ Million) Table 60. Global Poloxamer 338 Sales Market Share in Value by Application (2027-2032) Table 61. Global Poloxamer 338 Price by Application (2027-2032) & (US$/Ton) Table 62. North America Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 63. North America Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 65. Europe Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 69. Latin America Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Poloxamer 338 Sales by Application (2021-2026) & (US$ Million) Table 72. BASF Company Information Table 73. BASF Business Overview Table 74. BASF Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. BASF Poloxamer 338 Product Portfolio Table 76. BASF Recent Development Table 77. Croda Company Information Table 78. Croda Business Overview Table 79. Croda Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Croda Poloxamer 338 Product Portfolio Table 81. Croda Recent Development Table 82. Comercial Química Massó Company Information Table 83. Comercial Química Massó Business Overview Table 84. Comercial Química Massó Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Comercial Química Massó Poloxamer 338 Product Portfolio Table 86. Comercial Química Massó Recent Development Table 87. CD Formulation Company Information Table 88. CD Formulation Business Overview Table 89. CD Formulation Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. CD Formulation Poloxamer 338 Product Portfolio Table 91. CD Formulation Recent Development Table 92. North America Poloxamer 338 Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 93. North America Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 94. North America Poloxamer 338 Sales Market Share by Country (2021-2026) Table 95. North America Poloxamer 338 Sales Forecast by Country (2027-2032) & (Tons) Table 96. North America Poloxamer 338 Sales Market Share Forecast by Country (2027-2032) Table 97. North America Poloxamer 338 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Poloxamer 338 Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Poloxamer 338 Market Share by Country (2021-2026) Table 100. North America Poloxamer 338 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Poloxamer 338 Market Share Forecast by Country (2027-2032) Table 102. Europe Poloxamer 338 Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 103. Europe Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 104. Europe Poloxamer 338 Sales Market Share by Country (2021-2026) Table 105. Europe Poloxamer 338 Sales Forecast by Country (2027-2032) & (Tons) Table 106. Europe Poloxamer 338 Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Poloxamer 338 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Poloxamer 338 Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Poloxamer 338 Market Share by Country (2021-2026) Table 110. Europe Poloxamer 338 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Poloxamer 338 Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Poloxamer 338 Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 114. Asia-Pacific Poloxamer 338 Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Poloxamer 338 Sales Forecast by Country (2027-2032) & (Tons) Table 116. Asia-Pacific Poloxamer 338 Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Poloxamer 338 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Poloxamer 338 Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Poloxamer 338 Market Share by Country (2021-2026) Table 120. Asia-Pacific Poloxamer 338 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Poloxamer 338 Market Share Forecast by Country (2027-2032) Table 122. Latin America Poloxamer 338 Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 123. Latin America Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 124. Latin America Poloxamer 338 Sales Market Share by Country (2021-2026) Table 125. Latin America Poloxamer 338 Sales Forecast by Country (2027-2032) & (Tons) Table 126. Latin America Poloxamer 338 Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Poloxamer 338 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Poloxamer 338 Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Poloxamer 338 Market Share by Country (2021-2026) Table 130. Latin America Poloxamer 338 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Poloxamer 338 Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Poloxamer 338 Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 134. Middle East and Africa Poloxamer 338 Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Poloxamer 338 Sales Forecast by Country (2027-2032) & (Tons) Table 136. Middle East and Africa Poloxamer 338 Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Poloxamer 338 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Poloxamer 338 Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Poloxamer 338 Market Share by Country (2021-2026) Table 140. Middle East and Africa Poloxamer 338 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Poloxamer 338 Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Poloxamer 338 Distributors List Table 145. Poloxamer 338 Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Poloxamer 338 Image Figure 2. Global Poloxamer 338 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer 338 Market Size (2021-2032) & (US$ Million) Figure 4. Global Poloxamer 338 Sales (2021-2032) & (Tons) Figure 5. Purity 99% Image Figure 6. Global Purity 99% Sales YoY Growth (2021-2032) & (Tons) Figure 7. Purity 99.9% Image Figure 8. Global Purity 99.9% Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Poloxamer 338 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Poloxamer 338 Market Share by Type 2025 VS 2032 Figure 13. North America Poloxamer 338 Sales Market Share in Volume by Type in 2025 Figure 14. North America Poloxamer 338 Sales Market Share in Value by Type in 2025 Figure 15. Europe Poloxamer 338 Sales Market Share in Volume by Type in 2025 Figure 16. Europe Poloxamer 338 Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Poloxamer 338 Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Poloxamer 338 Sales Market Share in Value by Type in 2025 Figure 19. Latin America Poloxamer 338 Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Poloxamer 338 Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Poloxamer 338 Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Poloxamer 338 Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Poloxamer 338 Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cosmetic Image Figure 26. Global Cosmetic Sales YoY Growth (2021-2032) & (Tons) Figure 27. Pharmaceuticals Image Figure 28. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Poloxamer 338 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Poloxamer 338 Market Share by Application 2025 VS 2032 Figure 33. North America Poloxamer 338 Sales Market Share in Volume by Application in 2025 Figure 34. North America Poloxamer 338 Sales Market Share in Value by Application in 2025 Figure 35. Europe Poloxamer 338 Sales Market Share in Volume by Application in 2025 Figure 36. Europe Poloxamer 338 Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Poloxamer 338 Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Poloxamer 338 Sales Market Share in Value by Application in 2025 Figure 39. Latin America Poloxamer 338 Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Poloxamer 338 Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Poloxamer 338 Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Poloxamer 338 Sales Market Share in Value by Application in 2025 Figure 43. North America Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Poloxamer 338 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Poloxamer 338 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Poloxamer 338 Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Poloxamer 338 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Poloxamer 338 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Poloxamer 338 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Poloxamer 338 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Poloxamer 338 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Poloxamer 338 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Poloxamer 338 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Poloxamer 338 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Poloxamer 338 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Poloxamer 338 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Poloxamer 338 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Poloxamer 338 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Poloxamer 338 Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Poloxamer 338 Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 99%
  • Purity 99.9%
  • Others
Applications
  • Cosmetic
  • Pharmaceuticals
  • Others
Companies covered
  • BASF
  • Croda
  • Comercial Química Massó
  • CD Formulation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poloxamer 338 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Poloxamer 338 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Poloxamer 338 Market by Type
  6. 1.3.1 Purity 99%
  7. 1.3.2 Purity 99.9%
  8. 1.3.3 Others
  9. 1.4 Global Poloxamer 338 Market Size by Type
  10. 1.4.1 Global Poloxamer 338 Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Poloxamer 338 Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Poloxamer 338 Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Poloxamer 338 Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Poloxamer 338 Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Poloxamer 338 Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Poloxamer 338 Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Poloxamer 338 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Poloxamer 338 Industry Trends
  2. 2.2 Poloxamer 338 Industry Drivers
  3. 2.3 Poloxamer 338 Industry Opportunities and Challenges
  4. 2.4 Poloxamer 338 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Poloxamer 338 Revenue (2021-2026)
  2. 3.2 Global Top Players by Poloxamer 338 Sales (2021-2026)
  3. 3.3 Global Top Players by Poloxamer 338 Price (2021-2026)
  4. 3.4 Global Poloxamer 338 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poloxamer 338 Major Company Production Sites & Headquarters
  6. 3.6 Global Poloxamer 338 Company, Product Type & Application
  7. 3.7 Global Poloxamer 338 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poloxamer 338 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poloxamer 338 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Poloxamer 338 Tier 1, Tier 2, and Tier 3
4 Poloxamer 338 Regional Status and Outlook
  1. 4.1 Global Poloxamer 338 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Poloxamer 338 Historic Market Size by Region
  3. 4.2.1 Global Poloxamer 338 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Poloxamer 338 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Poloxamer 338 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Poloxamer 338 Forecasted Market Size by Region
  7. 4.3.1 Global Poloxamer 338 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Poloxamer 338 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Poloxamer 338 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Poloxamer 338 by Application
  1. 5.1 Poloxamer 338 Market by Application
  2. 5.1.1 Cosmetic
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Others
  5. 5.2 Global Poloxamer 338 Market Size by Application
  6. 5.2.1 Global Poloxamer 338 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Poloxamer 338 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Poloxamer 338 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Poloxamer 338 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Poloxamer 338 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Poloxamer 338 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Poloxamer 338 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Poloxamer 338 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BASF
  2. 6.1.1 BASF Company Information
  3. 6.1.2 BASF Business Overview
  4. 6.1.3 BASF Poloxamer 338 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BASF Poloxamer 338 Product Portfolio
  6. 6.1.5 BASF Recent Developments
  7. 6.2 Croda
  8. 6.2.1 Croda Company Information
  9. 6.2.2 Croda Business Overview
  10. 6.2.3 Croda Poloxamer 338 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Croda Poloxamer 338 Product Portfolio
  12. 6.2.5 Croda Recent Developments
  13. 6.3 Comercial Química Massó
  14. 6.3.1 Comercial Química Massó Company Information
  15. 6.3.2 Comercial Química Massó Business Overview
  16. 6.3.3 Comercial Química Massó Poloxamer 338 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Comercial Química Massó Poloxamer 338 Product Portfolio
  18. 6.3.5 Comercial Química Massó Recent Developments
  19. 6.4 CD Formulation
  20. 6.4.1 CD Formulation Company Information
  21. 6.4.2 CD Formulation Business Overview
  22. 6.4.3 CD Formulation Poloxamer 338 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CD Formulation Poloxamer 338 Product Portfolio
  24. 6.4.5 CD Formulation Recent Developments
7 North America by Country
  1. 7.1 North America Poloxamer 338 Sales by Country
  2. 7.1.1 North America Poloxamer 338 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Poloxamer 338 Sales by Country (2021-2026)
  4. 7.1.3 North America Poloxamer 338 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Poloxamer 338 Market Size by Country
  6. 7.2.1 North America Poloxamer 338 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Poloxamer 338 Market Size by Country (2021-2026)
  8. 7.2.3 North America Poloxamer 338 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Poloxamer 338 Sales by Country
  2. 8.1.1 Europe Poloxamer 338 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Poloxamer 338 Sales by Country (2021-2026)
  4. 8.1.3 Europe Poloxamer 338 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Poloxamer 338 Market Size by Country
  6. 8.2.1 Europe Poloxamer 338 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Poloxamer 338 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Poloxamer 338 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Poloxamer 338 Sales by Country
  2. 9.1.1 Asia-Pacific Poloxamer 338 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Poloxamer 338 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Poloxamer 338 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Poloxamer 338 Market Size by Country
  6. 9.2.1 Asia-Pacific Poloxamer 338 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Poloxamer 338 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Poloxamer 338 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Poloxamer 338 Sales by Country
  2. 10.1.1 South America Poloxamer 338 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Poloxamer 338 Sales by Country (2021-2026)
  4. 10.1.3 South America Poloxamer 338 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Poloxamer 338 Market Size by Country
  6. 10.2.1 South America Poloxamer 338 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Poloxamer 338 Market Size by Country (2021-2026)
  8. 10.2.3 South America Poloxamer 338 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Poloxamer 338 Sales by Country
  2. 11.1.1 Middle East and Africa Poloxamer 338 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Poloxamer 338 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Poloxamer 338 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Poloxamer 338 Market Size by Country
  6. 11.2.1 Middle East and Africa Poloxamer 338 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Poloxamer 338 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Poloxamer 338 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Poloxamer 338 Value Chain Analysis
  2. 12.1.1 Poloxamer 338 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Poloxamer 338 Production Mode & Process
  7. 12.2 Poloxamer 338 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Poloxamer 338 Distributors
  10. 12.2.3 Poloxamer 338 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst